Pharmaxis Announces ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge …
PR Newswire (press release) ARIDOL, the only dry powder bronchial challenge test approved for use in the United States, is used to assess bronchial hyperresponsiveness in patients six years of age and older who do not have clinically apparent asthma. ARIDOL should not be used as … |
View full post on asthma – Google News